Canan Alhan

1.7k total citations
32 papers, 520 citations indexed

About

Canan Alhan is a scholar working on Hematology, Genetics and Emergency Medicine. According to data from OpenAlex, Canan Alhan has authored 32 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 16 papers in Genetics and 9 papers in Emergency Medicine. Recurrent topics in Canan Alhan's work include Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Hematological disorders and diagnostics (9 papers). Canan Alhan is often cited by papers focused on Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Hematological disorders and diagnostics (9 papers). Canan Alhan collaborates with scholars based in Netherlands, Sweden and Italy. Canan Alhan's co-authors include Arjan A. van de Loosdrecht, Theresia M. Westers, Gert J. Ossenkoppele, Claudia Cali, Hetty J. Bontkes, Eline M.P. Cremers, Corien Eeltink, Birgit I. Lissenberg‐Witte, Maurice J. D. L. van der Vorst and Martine E.D. Chamuleau and has published in prestigious journals such as Blood, European Journal of Cancer and British Journal of Haematology.

In The Last Decade

Canan Alhan

23 papers receiving 510 citations

Peers

Canan Alhan
Arjan van de Loosdrecht Netherlands
Cristina Picone Italy
Janet Hayden United Kingdom
Lisa Eidenschink Brodersen United States
Nuria Fernández‐Mosteirín Spain
Christine Vaupel United States
Sairah Alvi United States
V. Shetty United States
P Anderlini United States
Paola Maria Cavigliano Italy
Arjan van de Loosdrecht Netherlands
Canan Alhan
Citations per year, relative to Canan Alhan Canan Alhan (= 1×) peers Arjan van de Loosdrecht

Countries citing papers authored by Canan Alhan

Since Specialization
Citations

This map shows the geographic impact of Canan Alhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Canan Alhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Canan Alhan more than expected).

Fields of papers citing papers by Canan Alhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Canan Alhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Canan Alhan. The network helps show where Canan Alhan may publish in the future.

Co-authorship network of co-authors of Canan Alhan

This figure shows the co-authorship network connecting the top 25 collaborators of Canan Alhan. A scholar is included among the top collaborators of Canan Alhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Canan Alhan. Canan Alhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Subirá, Dolores, Canan Alhan, Uta Oelschlaegel, et al.. (2021). Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome. Annals of Hematology. 100(7). 1711–1722. 3 indexed citations
4.
Duetz, Carolien, Theresia M. Westers, Eline M.P. Cremers, et al.. (2021). Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)‐mutant myelodysplastic syndromes subtype. British Journal of Haematology. 193(4). 798–803. 7 indexed citations
5.
Westers, Theresia M., Canan Alhan, Heleen Visser-Wisselaar, Dana Chiţu, & Arjan A. van de Loosdrecht. (2021). Dysplasia andPNH‐type cells in bone marrow aspirates of myelodysplastic syndromes. Cytometry Part B Clinical Cytometry. 104(2). 162–172. 1 indexed citations
6.
Duetz, Carolien, Sofie Van Gassen, Theresia M. Westers, et al.. (2020). Machine Learning-Based Flow Cytometry Diagnostics in Myelodysplastic Syndromes: Validation in the HOVON89 Clinical Trial (EudraCT 2008-002195-10). Blood. 136(Supplement 1). 10–12. 1 indexed citations
7.
Cremers, Eline M.P., Theresia M. Westers, Canan Alhan, et al.. (2016). Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes. Haematologica. 102(2). 320–326. 44 indexed citations
8.
Disselhorst, Maria, Chris Dickhoff, & Canan Alhan. (2016). Good's syndrome: an uncommon cause of therapy-resistant diarrhoea.. PubMed. 74(7). 309–12. 5 indexed citations
9.
Cremers, Eline M.P., Theresia M. Westers, Canan Alhan, et al.. (2015). Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias. European Journal of Cancer. 54. 49–56. 24 indexed citations
10.
Alhan, Canan, Theresia M. Westers, Eline M.P. Cremers, et al.. (2015). The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system. Leukemia. 30(3). 658–665. 27 indexed citations
11.
Cremers, Eline M.P., Canan Alhan, Theresia M. Westers, Gert J. Ossenkoppele, & Arjan A. van de Loosdrecht. (2014). Immunophenotyping for diagnosis and prognosis in MDS: Ready for general application?. Best Practice & Research Clinical Haematology. 28(1). 14–21. 10 indexed citations
12.
Alhan, Canan, Theresia M. Westers, Gerwin Huls, et al.. (2014). Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes. Cytometry Part B Clinical Cytometry. n/a–n/a. 12 indexed citations
13.
Veeger, Nic J.G.M., Marinus van Marwijk Kooy, Aart Beeker, et al.. (2013). Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts. Leukemia Research. 37(8). 877–882. 24 indexed citations
14.
Bontkes, Hetty J., Jurjen M. Ruben, Canan Alhan, et al.. (2012). Azacitidine differentially affects CD4pos T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes. Leukemia Research. 36(7). 921–930. 34 indexed citations
15.
Porta, Matteo Giovanni Della, Cristina Picone, Cristiana Pascutto, et al.. (2012). Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study. Haematologica. 97(8). 1209–1217. 110 indexed citations
16.
Picone, Cristina, Laura Vanelli, Luca Malcovati, et al.. (2011). MULTICENTRE VALIDATION OF A REPRODUCIBLE FLOW CYTOMETRIC SCORE FOR THE DIAGNOSIS OF LOWRISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A EUROPEAN LeukemiaNET STUDY. Cytometry Part A. 1051–1052. 1 indexed citations
17.
18.
Loosdrecht, Arjan A. van de, et al.. (2011). Role of immune responses in the pathogenesis of low‐risk MDS and high‐risk MDS: implications for immunotherapy. British Journal of Haematology. 153(5). 568–581. 79 indexed citations
19.
20.
Alhan, Canan, Theresia M. Westers, Gert J. Ossenkoppele, & Arjan A. van de Loosdrecht. (2008). Do peripheral blasts count in myelodysplastic syndromes?. Leukemia Research. 33(2). 209–211. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arjan van de Loosdrecht Breakdown of academic impact, for papers by Cristina Picone Breakdown of academic impact, for papers by Janet Hayden Breakdown of academic impact, for papers by Lisa Eidenschink Brodersen Breakdown of academic impact, for papers by Nuria Fernández‐Mosteirín Breakdown of academic impact, for papers by Christine Vaupel Breakdown of academic impact, for papers by Sairah Alvi Breakdown of academic impact, for papers by V. Shetty Breakdown of academic impact, for papers by P Anderlini Breakdown of academic impact, for papers by Paola Maria Cavigliano
Rankless by CCL
2026